Incannex Healthcare Faces Delisting Concerns

TL;DR

Incannex Healthcare might be delisted - big trouble ahead.

AI Summary

Incannex Healthcare Inc. filed an 8-K on October 22, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, previously known as Incannex Healthcare Ltd, is incorporated in Delaware and has its principal executive offices in Norwest, NSW, Australia.

Why It Matters

This filing indicates potential issues with Incannex Healthcare's continued listing on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's operations and stock value.

Key Players & Entities

• Incannex Healthcare Inc. (company) — Registrant
• Incannex Healthcare Ltd (company) — Former company name
• October 21, 2025 (date) — Earliest event reported
• October 22, 2025 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• Norwest, NSW, Australia (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
• $1.00 — hare (the "Common Stock"), closed below $1.00 per share for 30 consecutive trading da
• $1 — d price of the Common Stock is at least $1 per share for a minimum of 10 consecuti

Filing Documents

• ea0262074-8k_incannex.htm (8-K) — 30KB
• 0001213900-25-100980.txt ( ) — 195KB
• ixhl-20251021.xsd (EX-101.SCH) — 3KB
• ixhl-20251021_lab.xml (EX-101.LAB) — 33KB
• ixhl-20251021_pre.xml (EX-101.PRE) — 22KB
• ea0262074-8k_incannex_htm.xml (XML) — 4KB

01 Notice of Delisting or Failure to

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on April 23, 2025, Incannex Healthcare Inc. (the "Company") received a written notice (the "Notice") from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, because the closing bid price for the Company's common stock, par value $0.0001 per share (the "Common Stock"), closed below $1.00 per share for 30 consecutive trading days, the Company no longer met the minimum bid price requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the "Bid Price Requirement"). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until October 20, 2025, to regain compliance with the Bid Price Requirement. On July 10, 2025, the Company transferred the listing of its Common Stock from The Nasdaq Global Market to The Nasdaq Capital Market to meet the continued listing requirement for the market value of publicly held shares and all other initial listing standards, with the exception of the Bid Price Requirement. On October 21, 2025, the Company received a letter from the Staff notifying that the Company is eligible for a second 180-day period, or until April 20, 2026 (the "Second Grace Period") to regain compliance with the Bid Price Requirement. According to the notification from Nasdaq, the Staff's determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other Nasdaq initial listing standards, with the exception of the Bid Price Requirement, and (ii) the Company's written notice to Nasdaq of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If at any time during this Second Grace Period, the closing bid price of t

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the safe harbor provisions of the United such as "intends," "may," "will," "maintain," "continued," "confident," "potential," "expected" or other similar expressions. Such statements are subject to certain risks and uncertainties that may cause the Company's actual results to differ from the expectations expressed in the forward-looking statements. These risks include risks that (i) the Company may not be able to regain compliance with the Bid Price Requirement during any compliance period or in the future, whether through a reverse stock split or otherwise, (ii) a reverse stock split, if completed, may not result in the sustained price increase needed to regain Nasdaq compliance, (iii) the Company may not otherwise meet Nasdaq compliance standards for The Nasdaq Capital Market and may therefore be subject to delisting for additional deficiencies, (iv) any appeal of the Staff's decisions may be unsuccessful, (v) a reverse stock split would require stockholder approval and may require investor consent per the terms of the private placement, each which may not be obtained or obtained when needed in order for the Company to regain or maintain compliance with applicable Nasdaq compliance standards, and (vi) other risks as set forth in Item 1A "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended June 30, 2025 filed with the SEC on September 29, 2025 and subsequently filed reports. The forward-looking any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INCANNEX HEALTHCARE INC. Dated: October 22, 2025 By: /s/ Joel Latham Joel Latham Chief Executive Officer and President 3

View Full Filing

View this 8-K filing on SEC EDGAR